Adynovate recombinant and Pegloticase Intravenous
Determining the interaction of Adynovate recombinant and Pegloticase Intravenous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: antihemophilic factor
Brand name: Advate, Adynovate, Afstyla, Eloctate with Fc Fusion Protein, Helixate FS, Kogenate FS, Kovaltry, Novoeight, Nuwiq, Recombinate, Xyntha, Hemofil-M, Koate-DVI, Monoclate-P, Jivi, Obizur
Synonyms: Adynovate (recombinant)
Generic Name: pegloticase
Brand name: Krystexxa
Synonyms: Pegloticase
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Adynovate recombinant-Pegvaliase
- Adynovate recombinant-Pegvaliase-pqpz
- Adynovate recombinant-Pegvaliase-pqpz Subcutaneous
- Adynovate recombinant-Pegvisomant
- Adynovate recombinant-Pegvisomant Subcutaneous
- Adynovate recombinant-Pembrolizumab
- Pegloticase Intravenous-Adzenys ER
- Pegloticase Intravenous-Adzenys ER Oral Suspension
- Pegloticase Intravenous-Adzenys XR-ODT
- Pegloticase Intravenous-Aemcolo
- Pegloticase Intravenous-Aerobid
- Pegloticase Intravenous-Aerobid-M